Pilar Calero-Pérez

Metal-Free Radical Dendrimers as MRI Contrast Agents for Glioblastoma Diagnosis: Ex Vivo and In Vivo Approaches

J. Vidal-Gancedo, A. Candiota, S. Lope-Piedrafita, 2022, Biomacromolecules.

Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches

C. Arús, A. Candiota, Shuang Wu, 2020, International journal of molecular sciences.

Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

C. Arús, A. Candiota, Shuang Wu, 2021, Cancers.

Anti‐tumour immune response in GL261 glioblastoma generated by Temozolomide Immune‐Enhancing Metronomic Schedule monitored with MRSI‐based nosological images

Margarida Julià-Sapé, Carles Arús, Sandra Ortega-Martorell, 2020, NMR in biomedicine.

Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment

A. Candiota, J. Lorenzo, J. Bruna, 2022, Cancers.

Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy

A. Candiota, J. Lorenzo, J. Bruna, 2022, Nanomaterials.